Pharma's Medical Affairs faces growing internal and external challenges as well as new opportunities. We believe that at least three new, stronger forces will emerge that will greatly alter the healthcare landscape.
1. An increased focus on evidence and higher hurdles for providing product value.
2. Interactions between pharmaceutical companies and various medical stakeholders will continue to evolve. On top we will see a rise of consumerism in healthcare.
3. The number and types of users of medical data and information will continue to expand rapidly.